Aura Biosciences Analyst Ratings
Aura Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 154.35% | JMP Securities | $21 → $19 | Maintains | Market Outperform |
| 07/27/2023 | 207.9% | Scotiabank | → $23 | Initiates Coverage On | → Sector Outperform |
| 03/16/2023 | 234.67% | JMP Securities | $30 → $25 | Maintains | Outperform |
| 11/11/2022 | 301.61% | JMP Securities | $26 → $30 | Maintains | Market Outperform |
| 07/19/2022 | 248.06% | JMP Securities | → $26 | Initiates Coverage On | → Market Outperform |
| 11/23/2021 | 408.7% | BTIG | → $38 | Initiates Coverage On | → Buy |
| 11/23/2021 | 368.54% | Evercore ISI Group | → $35 | Initiates Coverage On | → Outperform |
| 11/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/23/2021 | 435.48% | SVB Leerink | → $40 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/10/2023 | 154.35% | JMP 證券 | 21 美元 → 19 美元 | 維護 | 市場表現跑贏大盤 |
| 07/27/2023 | 207.9% | 豐業銀行 | → 23 美元 | 啓動覆蓋範圍開啓 | → 板塊表現跑贏大盤 |
| 03/16/2023 | 234.67% | JMP 證券 | 30 美元 → 25 美元 | 維護 | 跑贏大盤 |
| 11/11/2022 | 301.61% | JMP 證券 | 26 美元 → 30 美元 | 維護 | 市場表現跑贏大盤 |
| 2022 年 7 月 19 日 | 248.06% | JMP 證券 | → 26 美元 | 啓動覆蓋範圍開啓 | → 市場跑贏大盤 |
| 11/23/2021 | 408.7% | BTIG | → 38 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/23/2021 | 368.54% | Evercore ISI 集團 | → 35 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 11/23/2021 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 11/23/2021 | 435.48% | SVB Leerink | → 40 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Aura Biosciences (AURA)?
Aura Biosciences（AURA）的目標價格是多少？
The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by JMP Securities on November 10, 2023. The analyst firm set a price target for $19.00 expecting AURA to rise to within 12 months (a possible 154.35% upside). 4 analyst firms have reported ratings in the last year.
JMP Securities於2023年11月10日公佈了光環生物科學（納斯達克股票代碼：AURA）的最新目標股價。該分析公司將目標股價定爲19.00美元，預計AURA將在12個月內升至12個月內（可能上漲154.35％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Aura Biosciences (AURA)?
Aura Biosciences（AURA）的最新分析師評級是多少？
The latest analyst rating for Aura Biosciences (NASDAQ: AURA) was provided by JMP Securities, and Aura Biosciences maintained their market outperform rating.
Aura Biosciences（納斯達克股票代碼：AURA）的最新分析師評級由JMP Securities提供，Aura Biosciences維持其跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Aura Biosciences（AURA）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Aura Biosciences的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Aura Biosciences的最新評級是在2023年11月10日發佈的，因此您應該預計下一個評級將在2024年11月10日左右公佈。
Is the Analyst Rating Aura Biosciences (AURA) correct?
分析師評級Aura Biosciences（AURA）是否正確？
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a maintained with a price target of $21.00 to $19.00. The current price Aura Biosciences (AURA) is trading at is $7.47, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Aura Biosciences（AURA）評級維持不變，目標股價爲21.00美元至19.00美元。Aura Biosciences（AURA）目前的交易價格爲7.47美元，超出了分析師的預期區間。